Beijing Science Sun Pharmaceutical Co Ltd - Asset Resilience Ratio
Beijing Science Sun Pharmaceutical Co Ltd (300485) has an Asset Resilience Ratio of 43.40% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Beijing Science Sun Pharmaceutical Co Lt PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2024)
This chart shows how Beijing Science Sun Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Beijing Science Sun Pharmaceutical Co Lt (300485) net asset quality to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Beijing Science Sun Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Beijing Science Sun Pharmaceutical Co Lt (300485) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.56 Billion | 43.4% |
| Total Liquid Assets | CN¥1.56 Billion | 43.40% |
Asset Resilience Insights
- Very High Liquidity: Beijing Science Sun Pharmaceutical Co Ltd maintains exceptional liquid asset reserves at 43.40% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Beijing Science Sun Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Beijing Science Sun Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 11.60% |
|
SIMCERE PHARMAC. GRP LTD
F:S2P |
Drug Manufacturers - Specialty & Generic | 0.44% |
|
Curaleaf Holdings Inc.
TO:CURA |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755 |
Drug Manufacturers - Specialty & Generic | 24.59% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
Annual Asset Resilience Ratio for Beijing Science Sun Pharmaceutical Co Ltd (2015–2024)
The table below shows the annual Asset Resilience Ratio data for Beijing Science Sun Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 42.13% | CN¥1.50 Billion ≈ $218.96 Million |
CN¥3.55 Billion ≈ $519.75 Million |
+13.05pp |
| 2023-12-31 | 29.08% | CN¥1.05 Billion ≈ $154.15 Million |
CN¥3.62 Billion ≈ $530.04 Million |
+3.99pp |
| 2022-12-31 | 25.09% | CN¥895.39 Million ≈ $131.02 Million |
CN¥3.57 Billion ≈ $522.27 Million |
-8.27pp |
| 2021-12-31 | 33.35% | CN¥1.13 Billion ≈ $166.03 Million |
CN¥3.40 Billion ≈ $497.77 Million |
+16.38pp |
| 2020-12-31 | 16.97% | CN¥507.69 Million ≈ $74.29 Million |
CN¥2.99 Billion ≈ $437.69 Million |
-0.47pp |
| 2019-12-31 | 17.44% | CN¥489.34 Million ≈ $71.61 Million |
CN¥2.81 Billion ≈ $410.53 Million |
+17.54pp |
| 2018-12-31 | -0.10% | CN¥-2.66 Million ≈ $-389.17K |
CN¥2.76 Billion ≈ $403.96 Million |
-22.88pp |
| 2016-12-31 | 22.78% | CN¥505.00 Million ≈ $73.90 Million |
CN¥2.22 Billion ≈ $324.36 Million |
-6.78pp |
| 2015-12-31 | 29.57% | CN¥575.00 Million ≈ $84.14 Million |
CN¥1.94 Billion ≈ $284.59 Million |
-- |
About Beijing Science Sun Pharmaceutical Co Ltd
Beijing Science Sun Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of injections in China. The company offers products for cardiovascular, cerebrovascular, immunomodulation, and nervous systems, among others. It is also involved in the research, development, production, and sale of raw materials; the extraction of traditional Chin… Read more